SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)

Trial Profile

SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms GINAII
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Nov 2008 Actual end date changed from Mar 2006 to Jul 2007 as reported by ClinicalTrials.gov.
    • 28 Feb 2008 Status changed from in progress to completed.
    • 16 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top